File Download
  Patent History
  • Application
    US 12/113056 2008-04-30
  • Publication
    US 20090274709 2009-11-05
  • Granted
    US 8030097 2011-10-04

granted patent: Lipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risks

TitleLipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risks
Granted PatentUS 8030097
Granted Date2011-10-04
Priority Date2008-04-30 US 12/113056
Inventors
Issue Date2011
Citation
US Patent 8030097. Washington, DC: US Patent and Trademark Office (USPTO), 2011 How to Cite?
AbstractMethods And Apparatus Are Disclosed For The Measurement Of Lipocalin-2 In Body Fluids (Including But Not Limited To Blood, Serum, Plasma, Urine, Saliva, Tear, Etc.) By An Assay Such As An Immunoassay Or An Immunotest For (1) The Prediction Of Risk Of Future Cardiovascular Diseases; And (2) The Determination Of The Likelihood That Certain Individuals Will Benefit To A Greater Or Lesser Extent From The Use Of Certain Treatments Designed To Prevent And/Or Treat Cardiovascular Diseases.
Persistent Identifierhttp://hdl.handle.net/10722/173806
References

 

DC FieldValueLanguage
dc.date.accessioned2012-11-02T06:19:25Z-
dc.date.available2012-11-02T06:19:25Z-
dc.date.issued2011-
dc.identifier.citationUS Patent 8030097. Washington, DC: US Patent and Trademark Office (USPTO), 2011en_HK
dc.identifier.urihttp://hdl.handle.net/10722/173806-
dc.description.abstractMethods And Apparatus Are Disclosed For The Measurement Of Lipocalin-2 In Body Fluids (Including But Not Limited To Blood, Serum, Plasma, Urine, Saliva, Tear, Etc.) By An Assay Such As An Immunoassay Or An Immunotest For (1) The Prediction Of Risk Of Future Cardiovascular Diseases; And (2) The Determination Of The Likelihood That Certain Individuals Will Benefit To A Greater Or Lesser Extent From The Use Of Certain Treatments Designed To Prevent And/Or Treat Cardiovascular Diseases.en_HK
dc.relation.isreferencedbyWO 2011100426 (A2) 2011-08-18en_HK
dc.relation.isreferencedbyWO 2011100426 (A3) 2011-12-22en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleLipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risksen_HK
dc.typePatenten_US
dc.identifier.emailXu, A=amxu@hkucc.hku.hk-
dc.identifier.authorityWang, Y:rp00239-
dc.identifier.authorityWang, Y:rp00239-
dc.identifier.authorityXu, A:rp00485-
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorXu, A-
dc.contributor.inventorWang, Y-
dc.contributor.inventorRenneberg, R-
dc.contributor.inventorCautherley, GWH-
dc.contributor.inventorChan, CPY-
dc.contributor.inventorLehmann, M-
patents.identifier.applicationUS 12/113056en_HK
patents.identifier.grantedUS 8030097en_HK
patents.description.assigneeVersitech Ltd And R & C Biogenius Ltd [Cn]en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2009-11-05en_HK
patents.date.granted2011-10-04en_HK
dc.relation.referencesUS 2005244892 (A1) 2005-11-03en_HK
dc.relation.referencesUS 2008254485 (A1) 2008-10-16en_HK
dc.relation.referencesUS 7842472 (B2) 2010-11-30en_HK
patents.identifier.hkutechidMedi-2008-00273-1en_HK
patents.date.application2008-04-30en_HK
patents.date.priority2008-04-30 US 12/113056en_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 20090274709en_HK
patents.relation.familyCN 102026655 (A) 2011-04-20en_HK
patents.relation.familyEP 2300048 (A1) 2011-03-30en_HK
patents.relation.familyJP 2011519037 (A) 2011-06-30en_HK
patents.relation.familyUS 2009274709 (A1) 2009-11-05en_HK
patents.relation.familyUS 8030097 (B2) 2011-10-04en_HK
patents.relation.familyWO 2009132510 (A1) 2009-11-05en_HK
patents.description.kindB2en_HK
patents.typePatent_granteden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats